🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cutaneous Lymphoma

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites📍 Duarte📍 La Jolla📍 Ann Arbor Incyte Corporation · Tests: INCA036873 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma NCT04128072Phase 213 sites📍 Copenhagen📍 Bordeaux📍 Paris European Organisation for Research and Treatment of Cancer … · Tests: Mogamulizumab, Total Skin Electron Beam Therapy (TSEB), Mogamulizumab (subsequent cycles post TSEB) Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778Phase 1, Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Duvelisib, Venetoclax SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites📍 Nijmegen📍 Maastricht📍 Amsterdam Leiden University Medical Center Combating Cancer-Related Fatigue: A Personalized Supportive Care Program NCT06860880NA1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Exercise, Diet Amping up With PemJAK NCT07283822Phase 21 site📍 New York Seda S. Tolu · Tests: Ruxolitinib, Pembrolizumab TreAtments and outComes in paTients With prImary CutAneous Lymphoma NCT05518851n/a5 sites📍 Beijing📍 Guandong📍 Nanjing Peking University First Hospital Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma NCT06588868n/a18 sites📍 Ancona📍 Bari📍 Bari Fondazione Italiana Linfomi - ETS Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 NCT04670874n/a1 site📍 Duarte City of Hope Medical Center · Tests: Quality-of-Life Assessment, Questionnaire Administration A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA NCT06698822Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: tofacitinib 2% cream A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma NCT04045470NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Microdevices, Standard of care therapy, Standard of care systemic therapy Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801n/a6 sites📍 Aurora📍 Atlanta📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid)… National Epidemiology of Cutaneous Lymphomas NCT07463989n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies NCT05544968Phase 11 site📍 Milwaukee Medical College of Wisconsin · Tests: anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC), GM-CSF Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653Phase 23 sites📍 Scottsdale📍 Duarte📍 Atlanta City of Hope Medical Center · Tests: Extracorporeal Photopheresis, Mogamulizumab, Quality-of-Life Assessment, Questionnaire Administration A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL NCT06854653Phase 215 sites📍 Duarte📍 Irvine📍 New Haven Prescient Therapeutics, Ltd. · Tests: PTX-100 Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) NCT07047885Phase 11 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Ropeginterferon alfa-2b Characterization of the Microbiome in Cutaneous T Cell Lymphoma NCT03932279n/a1 site📍 Chicago Northwestern University Extracorporeal Photopheresis in Sezary Syndrome NCT05157581n/a3 sites📍 Atlanta📍 Baltimore📍 Pittsburgh Oleg E. Akilov, MD, PhD · Tests: Extracorporeal photopheresis (ECP), Methoxsalen Injection A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma NCT06436677n/a3 sites📍 Beijing📍 Beijing📍 Beijing Peking University First Hospital · Tests: molecular subtype based treatment A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides NCT05296304Phase 13 sites📍 Commack📍 New York📍 Rockville Centre Memorial Sloan Kettering Cancer Center · Tests: Bexarotene, Total Skin Electron Beam (TSEB) Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients NCT03587844Phase 28 sites📍 Stanford📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: brentuximab vedotin, brentuximab vedotin, brentuximab vedotin Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma NCT05996185Phase 22 sites📍 New Haven📍 New York Yale University · Tests: Mogamulizumab, DA-EPOCH Protocol, CHOEP protocol Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome NCT02848274n/a13 sites📍 Duarte📍 Palo Alto📍 Iowa City Stanford University Photopheresis in Early-stage Mycosis Fungoides NCT05680558Phase 21 site📍 New York Columbia University · Tests: UVADEX® (methoxsalen) Sterile Solution in conjunction with the THERAKOS® CELLEX Photopheresis, THERAKOS® CELLEX photoph… Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment NCT01087333n/a1 site📍 Bethesda National Cancer Institute (NCI) Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas NCT05956041Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Pembrolizumab, Mogamulizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy